MGN
NASDAQ
MY
Megan Holdings Limited - Class A Ordinary Shares
$0.15
▼ $-0.01
(-3.85%)
Vol 2.6M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$25.0M
Beta
0.59
52W
$1–$9
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2023-12-31 | 2024-12-31 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 9.8% | 8.0% | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 1.30 | 1.03 | — | — | — | — |
| Current Ratio | 2.04 | 1.84 | — | — | — | — |
Key Ratios
52W High
$8.63
52W Low
$1.30
$1.30
52-Week Range
$8.63
How does MGN compare to Construction peers?
Peer group: Micro-cap Construction (All) · 36 companies
MGN valuation vs Construction peers
P/E ratio
—
▼
0%
below
peers
(26.2)
vs Peers
vs Industry
Fair value
P/S ratio
—
▼
0%
below
peers
(1.5)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(4.9)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.8%)
vs Peers
vs Industry
Low yield
MGN profitability vs Construction peers
ROE
—
▼
0%
below
peers
(9.7%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(3.5%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(23.1%)
vs Peers
vs Industry
Top tier
ROA
—
▼
0%
below
peers
(3.5%)
vs Peers
vs Industry
Top tier
MGN financial health vs Construction peers
D/E ratio
—
▼
0%
below
peers
(34.6)
vs Peers
vs Industry
High debt
Current ratio
—
▼
0%
below
peers
(1.3)
vs Peers
vs Industry
Strong liquidity
Beta
0.6
▼
41%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
MGN fundamentals radar
MGN
Peer median
Industry
MGN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MGN vs peers: key metrics
Latest News
Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from …
Yahoo Finance · Mar 25
Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position
Yahoo Finance · Mar 19
Magnite (MGNI), NOVA Entertainment Partner to Enable Programmatic Audio in Australia
Yahoo Finance · Mar 17
Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies
Yahoo Finance · Mar 17